近五年第一作者及通讯作者论文
(1) Lu J#*, Zhang Y#, Dong HY, Sun JJ, Zhu L, Liu PY, Wen FL, Lin R, New mechanism of nephrotoxicity of triptolide: Oxidative stress promotes cGAS-STING signaling pathway, Free Radic Biol Med. 2022; 188:26-34. IF: 8.101，通讯作者及第一作者.
(2) Li XH#, Zhang ZT#, Yu YJ#, Cai W, Xu XJ, Xie K, Lin X, Lin L, Lu J*, Chen P*, Activation of the STING-IRF3 Pathway Involved in Psoriasis with Diabetes Mellitus, J Cell Mol Med. 2022; 26(8):2139-2151. IF:5.310，并列通讯作者.
(3) Dong HY#, Zhu L#, Sun JJ #, Zhang Y, Cui Q, Wu L, Chen SS, Lu J*, Pan-cancer Analysis of NEDD4L and Its Tumor Suppressor Effects in Clear Cell Renal Cell Carcinoma, Journal of Cancer, 2021, 12(20): 6242-6253. IF:4.204, 通讯作者.
(4) Lu J*#, Zhang Y#, Sun JJ*#, Huang SL, Wu WZ, Tan JM, The Immune Cell Landscape in Renal Allografts, Cell transplantation, 2021, 30:1-9. IF:4.064
(5) Lu J*#, Tan T#, Zhu L, Dong HY, Xian RH*, Hypomethylation Causes MIR21 Overexpression in Tumors, Molecular therapy-Oncolytics, 2020, 18:47-57. IF:7.2, 第一作者，第一通信作者
(6) Lu J#*; Chen Z#; Zhao H#; Dong HY#; Zhu L; Zhang Y; Wang J; Zhu HH; Cui Q; Qi C; Wang SL; Chen SS; Shao JC*; ABAT and ALDH6A1, regulated by transcription factor HNF4A, suppress tumorigenic capability in clear cell renal cell carcinoma, Journal of Translational Medicine, 2020, 18(1), 101. IF: 5.531，第一作者，第一通信作者。
(7) Zhao H*, Chen JQ, Chen J, Kong XH, Zhu HH, Zhang YP, Dong HY, Wang J, Ren Q, Wang QH, Chen SS, Deng Z, Chen Z, Cui Q, Zheng JQ, Lu J*, Wang SL*, Tan JM*, miR-192/215-5p act as tumor suppressors and link Crohn's disease and colorectal cancer by targeting common metabolic pathways: An integrated informatics analysis and experimental study, Journal of cellular physiology, 2019, 234(11): 21060-21075. 当年IF: 4.522，共同通讯作者。
(8) Wang J, Zhao H, Dong HY, Zhu L, Wang SL, Wang P, Ren Q, Zhu HH, Chen JQ, Lin ZJ, Cheng YH, Qian BJ, Zhang Y, Jia RX, Wu WZ, Lu J*, Tan JM*. LAT, HOXD3 and NFE2L3 identified as novel DNA methylation-driven genes and prognostic markers in human clear cell renal cell carcinoma by integrative bioinformatics approaches, Journal of Cancer, 2019, 10(26): 6726 – 6737, 当年IF: 3.182，共同通讯作者。
(9) Shen ZJ*, Zhu L, Zhang C, Cui XB, Lu J* , Overexpression of BHLHE41, correlated with DNA hypomethylation in 3'UTR region, promotes the growth of human clear cell renal cell carcinoma, Oncology Reports, 2019, 41(4): 2137-2147, 当年IF:2.979, 共同通讯作者。
(10) Lu J*, Zhu LF, Cai YM, Dong HY, Zhu L, Tan JM*. Isolation and multipotential differentiation of mesenchymal stromal cell‑like progenitor cells from human bladder, Molecular Medicine Reports, 2019，19: 187-194. 当年IF:1.851，第一作者，通讯作者。
(11) Lu J*, Zhu L, Zheng LP, Cui Q, Zhu HH, Zhao H, Shen ZJ, Dong HY, Chen SS, Wu WZ*, Tan JM*. Overexpression of ULK1 Represents a Potential Diagnostic Marker for Clear Cell Renal Carcinoma and the Antitumor Effects of SBI-0206965, Ebiomedicine, 2018, 34: 85-93. 当年IF:6.68，第一作者，共同通讯作者。
(12) Zhu HH, Lu J*, Zhao H, Chen Z, Cui Q, Lin ZW, Wang XY, Wang J, Dong HY, Wang SL, Tan JM*. Functional Long Noncoding RNAs (lncRNAs) in Clear Cell Kidney Carcinoma Revealed by Reconstruction and Comprehensive Analysis of the lncRNA–miRNA–mRNA Regulatory Network. Medical Science Monitor, 2018, 24: 8250-8263. 当年IF=1.98, 并列第一作者，通讯作者。
(13) Lu J*, Wang QH, Huang LH, Dong HY, Lin LJ, Tan JM*. Correlation of CDC42 Activity with Cell Proliferation and Palmitate-mediated Cell Death in Human umbilical cord Wharton’s jelly derived Mesenchymal Stromal cells, Stem Cells and Development, 2017, 26(17): 1283-1292. 当年IF:3.315，第一作者，共同通讯作者。
